Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II trials assess belinostat in bladder cancer and hepatocellular carcinoma

Oct. 24, 2011

Pazopanib activity reported in soft tissue sarcoma and urothelial cancer

Oct. 24, 2011

Study suggests montelukast improves pediatric atopic dermatitis

Oct. 24, 2011

Findings disclosed from ATON study evaluating atacicept in optic neuritis

Oct. 21, 2011

Promising 96-week data reported from phase II ocrelizumab trial in RRMS

Oct. 21, 2011

New antibacterials show activity against Gram-positive and -negative pathogens

Oct. 21, 2011

Further phase I data reported on GDC-941 in metastatic and advanced cancer

Oct. 21, 2011

Analysis of TIRASMUS data identifies possible marker of temsirolimus efficacy in colorectal cancer

Oct. 21, 2011

Clinical data analyses examine efficacy and safety of lorcaserin

Oct. 20, 2011

Korean scientists identify serum biomarkers of preeclampsia

Oct. 20, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...